Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Wang Jiale, Liu Longcheng, Lu Peipei, Ma Lihong. Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention. // Clinical Cardiology. – 2026. – DOI: 10.1002/clc.70512. – URL: https://onlinelibrary.wiley.com/doi/10.1002/clc.70512?af=R
Wang Jiale, Liu Longcheng, Lu Peipei, & Ma Lihong (2026). Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clinical Cardiology. https://doi.org/10.1002/clc.70512
Wang Jiale, et al. “Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention.” Clinical Cardiology, 2026. doi:10.1002/clc.70512.
@article{Jiale2026,
title = {Inflammatory and Insulin Resistance Indicator for Predicting Repeat Revascularization and In‐Stent Restenosis in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention},
author = {Jiale, Wang and Longcheng, Liu and Peipei, Lu and Lihong, Ma},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70512},
url = {https://onlinelibrary.wiley.com/doi/10.1002/clc.70512?af=R}
}